Scott A. Beardsley

Director/Board Member at

Anthos Therapeutics, Inc.

58 year

50 connections

Finance

Health Technology

Consumer Services

Profile

Scott A. Beardsley is currently the Director at Anthos Therapeutics, Inc. and the Managing Partner at Novo Ventures (US), Inc. He previously worked as a Managing Director at JPMorgan Securities LLC, Managing Director at Piper Jaffray Cos., Independent Director at Inogen, Inc., Independent Director at Aerocrine AB, and Senior Partner at Novo Principal Investments.
Mr. Beardsley has an undergraduate degree from Colorado State University and an MBA from UCLA Anderson School of Management.

Scott A. Beardsley active positions

Companies	Position	Start
Novo Ventures (US), Inc. Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world.	Private Equity Investor	2011-12-31
Anthos Therapeutics, Inc. Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases	Director/Board Member	-

All active positions of Scott A. Beardsley

Former positions of Scott A. Beardsley

Companies	Position	End
INOGEN, INC.	Director/Board Member	2021-02-11
AEROCRINE AB	Director/Board Member	2014-05-11
Piper Jaffray Cos. Piper Jaffray Cos. Investment Banks/BrokersFinance Provides broker and investment banking services	Corporate Officer/Principal	2005-12-31
Unchained Labs Unchained Labs BiotechnologyHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research	Director/Board Member	-
JPMorgan Securities LLC JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions	Analyst-Equity	-

See the detail of Scott A. Beardsley's experience

Training of Scott A. Beardsley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott A. Beardsley's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
JPMorgan Securities LLC JPMorgan Securities LLC Investment Banks/BrokersFinance Provides corporate, investment banking, consumer and commercial banking, asset management, payment & security solutions	Finance
Piper Jaffray Cos. Piper Jaffray Cos. Investment Banks/BrokersFinance Provides broker and investment banking services	Finance
Inogen, Inc. Inogen, Inc. Medical SpecialtiesHealth Technology Operates as a medical technology company	Health Technology
Aerocrine AB Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Manufactures and distributes medical devices for asthma patients	Electronic Technology
Colorado State University Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novo Ventures (US), Inc. Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures US invests venture capital in biotechnology and life science companies throughout the US and Europe. Their typical investments are as equity ranging from 1 to 15 million Euro. The firm may invest at any stage of development of a business idea - from seed capital over private placements to IPOs and public companies and they may invest in any part of the world.	Finance
UCLA Anderson School of Management UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Unchained Labs Unchained Labs BiotechnologyHealth Technology Designs, develops and manufactures tools & devices for biologics and gene therapy research	Health Technology
Anthos Therapeutics, Inc. Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases	Health Technology